Correlation Between Edesa Biotech and MiMedx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and MiMedx Group, you can compare the effects of market volatilities on Edesa Biotech and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and MiMedx.

Diversification Opportunities for Edesa Biotech and MiMedx

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Edesa and MiMedx is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and MiMedx go up and down completely randomly.

Pair Corralation between Edesa Biotech and MiMedx

Given the investment horizon of 90 days Edesa Biotech is expected to generate 4.05 times more return on investment than MiMedx. However, Edesa Biotech is 4.05 times more volatile than MiMedx Group. It trades about 0.11 of its potential returns per unit of risk. MiMedx Group is currently generating about -0.19 per unit of risk. If you would invest  168.00  in Edesa Biotech on November 1, 2024 and sell it today you would earn a total of  21.00  from holding Edesa Biotech or generate 12.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  MiMedx Group

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
MiMedx Group 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point.

Edesa Biotech and MiMedx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and MiMedx

The main advantage of trading using opposite Edesa Biotech and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.
The idea behind Edesa Biotech and MiMedx Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins